- Home
- RLAY vs NIC Comparison
RLAY vs NIC Comparison
Compare RLAY & NIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | NIC |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.6B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | RLAY | NIC |
|---|---|---|
| Price | $18.41 | $172.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $27.58 | ★ $194.20 |
| AVG Volume (30 Days) | ★ 2.4M | 150.1K |
| Earning Date | 11-04-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 0.83% |
| EPS Growth | ★ 31.78 | 21.49 |
| EPS | N/A | ★ 6.57 |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $75.22 |
| Revenue Next Year | $60.15 | $8.76 |
| P/E Ratio | ★ N/A | $26.67 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $5.95 | $118.33 |
| 52 Week High | $21.27 | $180.00 |
Technical Indicators
Market Signals| Indicator | RLAY | NIC |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 57.29 |
| Support Level | $17.45 | $162.11 |
| Resistance Level | $20.31 | $180.00 |
| Average True Range (ATR) | 1.15 | 4.20 |
| MACD | -0.04 | 0.50 |
| Stochastic Oscillator | 44.29 | 59.93 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About NIC Nicolet Bankshares Inc.
Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.